#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital ectodermal dysplasia Plasma cell myeloma recurrent Autoimmune disorder Extraskeletal ossification T-cell lymphoma Mucopolysaccharidosis II Vascular calcification Immunodeficiency common variable Small cell lung cancer Arrhythmogenic right ventricular dysplasia Immune-mediated myositis Peripheral primitive neuroectodermal tumour of soft tissue Hereditary angioedema Hypertriglyceridaemia B-cell lymphoma recurrent More trials…

    Learn about Rare Diseases

    Amyotrophic lateral sclerosis – Treatment Primary hyperoxaluria – Life with Disease Systemic sclerosis pulmonary Alagille syndrome – Diagnostics Pulmonary sarcoidosis – Life with Disease Biotinidase deficiency – Trials in Disease Activated PI3 kinase delta syndrome – Basic Information Nephrotic syndrome – Life with Disease Carcinoid syndrome – Basic Information Proteus syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Octocog Alfa Vh4524184 Datopotamab Deruxtecan Rondaptivon Pegol Delandistrogene Moxeparvovec Sodium 2-Hydroxylinoleate Polatuzumab Vedotin ASP2957 Tramadol Tipiracil Hydrochloride Dobutamine Rezpegaldesleukin Golodirsen Gimeracil Methotrexate Sodium Feladilimab Caffeine Citrate Atacicept Platelet Concentrate Fluoxetine Hydrochloride More therapies…

    Learn about Your Condition

    Otitis media Hepatocellular carcinoma Rhabdomyosarcoma Diabetic foot Retinoblastoma Rectal cancer Frontotemporal dementia Cough Hypoglycaemia Methylmalonic acidaemia Candida infection Viral myocarditis Mite allergy Lyme disease Breast cancer male More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mygxkl Zgafyzqb Kwboz 2vz Dgtzszuik 4iokm Hmidgqj

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of Encoberminogene Rezmadenovec Gene Therapy for Patients with Refractory Angina Due to Coronary Artery Disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Angina pectoris
    Investigated Drugs:
    • 13N-AMMONIA
    Belgium Germany Hungary The Netherlands Poland

  • Study of Telitacicept compared to placebo in adults with moderate to severe systemic lupus erythematosus

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Telitacicept
    Bulgaria Czechia France Germany Hungary Poland +1

  • Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

    Not yet recruiting

    3 1
    Austria Belgium Bulgaria Czechia Denmark France +11

  • Long-term Safety and Effectiveness Evaluation of RGX-314 in Patients with Neovascular Age-related Macular Degeneration

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    France Germany Hungary Italy Spain

  • Study on Aztreonam, Avibactam, and Metronidazole for Treating Infections in Neonates and Infants Under 9 Months with Gram-Negative Bacterial Infections

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Bacterial infection
    • Abdominal infection
    • Haematological infection
    Investigated Drugs:
    • Avibactam Sodium
    • Aztreonam
    • Metronidazole
    Bulgaria Greece Hungary Italy Slovakia Spain

  • Study on Datopotamab Deruxtecan and Rilvegostomig for Stage I Non-Small Cell Lung Cancer Patients with ctDNA-Positive or High-Risk Features

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage I
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Datopotamab Deruxtecan
    Belgium France Germany Hungary Italy The Netherlands +3

  • Study on Airway Changes in Patients with Residual Neuromuscular Blockade Using Sugammadex and Rocuronium Bromide

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Rocuronium Bromide
    • Sugammadex
    Hungary

  • Study on the Safety and Effects of SPL84 for Patients with Cystic Fibrosis

    Not yet recruiting

    2 1
    Czechia France Germany Hungary Italy Lithuania +4

  • Study of Avacopan Safety and Effectiveness in Patients with ANCA-associated Vasculitis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated Drugs:
    • Avacopan
    • Azathioprine
    • Cyclophosphamide
    Czechia Denmark France Greece Hungary Poland +1

  • Study on the Effects of Rapcabtagene Autoleucel in Patients with Systemic Lupus Erythematosus and Active, Refractory Lupus Nephritis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    • Lupus nephritis
    Investigated Drugs:
    • Voclosporin
    • Azathioprine
    • Belimumab
    Austria Czechia Denmark France Germany Hungary +7
Previous Page
1 … 19 20 21 22 23 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!